not long ago, @recursionpharma and Valence Labs announced the opening of their london office to accelerate ai for drug discovery and design i'm really happy that we'll have Dan at RAAIS this year dan is president of valence labs, which is a gem of an org :-)

Looking forward to this!

Thanks to everyone who came out yesterday! Looking forward to sharing more about our work at RAAIS later today.

Thanks to everyone who came out and hope to see you again next year!

Last week our Deputy Mayor for Business and Chair of London & Partners Howard Dawber along with our North American team was honoured to attend the opening of Recursion new office in #London at Pancras Square, King’s Cross 👏. The site will provide Recursion and Valence Labs,

“I’m a shareholder, Recursion is the largest investment we’ve ever made .. outside of our own company” - Jensen Huang at (standing room only) Recursion 2024 Download Day

The Valence Labs team will be in Vienna for ICML next week. Join us and other TechBio friends at the Polaris launch party on Thurs night to learn more :)

🚀 Polaris is here! It's time to stop overfitting on the same 3 benchmarks in drug discovery.

Benchmarking is hard...but it doesn't have to be! Excited to see Polaris launched at #ICML2024 today, w support from an awesome steering committee of industry leaders, to help up-level our collective research community. Excited to get everyone's feedback on this one :)

As someone who has spent a lot of time writing, talking, and complaining about the sad state of benchmarks in our field, I'm incredibly excited by the Polaris platform. This effort will enable the community to easily share datasets and best practices for ML model validation.

Today, at the ICML workshops, Prudencio M Tossou shared some details on our QM data generation efforts and Emmanuel Bengio discussed the latest on GFlowNets. Come chat with us and learn more about our open roles in London. We're hiring! valencelabs.com/careers

Thanks to everyone who came out, and the teams Valence Labs and Mila - Institut québécois d'IA for organizing!

Announcing the 1st #neuroscience phenomap – “Neuromap” – optioned under our collaboration with Roche and @Genentech for $30m. To build it, we produced over 1 trillion hiPSC-derived #neuronal cells – one of the largest such datasets – & scaled new genetic perturbation techniques.

Huge day for Recursion and for neuroscience - so proud of our team for doing so many world firsts to achieve this and so excited to be working with the exceptional teams at Roche and Genentech to make great strides towards new neuro targets!

In biology, unpaired data is the norm as experiments are often destructive. This limits our ability to build powerful multimodal models for drug discovery. To fuel a multimodal future in TechBio, we propose a simple algorithm for matching. 🧵 youtu.be/7a29mGz9LXI

News! Modal is supporting @RAAIS fellowships with $10,000 credits on their platform, alongside the $5,000 GPU credits from Lambda. Working on AI-first, open source research outside big institutions? Apply at airstreet(dot)com/fellowships

🎉 It’s a clean sweep! This past weekend at NeurIPS Conference, the world's most prestigious #ML conference, papers from Valence Labs & Recursion won first, second and third place awards at the Foundation Models for Science workshop. The winning papers offer breakthroughs in leveraging